TCI Wealth Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-64
| Closed | -$2.31K | – | 1821 |
|
|
2023
Q1 | $2.31K | Sell |
64
-172
| -73% | -$6.2K | ﹤0.01% | 1933 |
|
|
2022
Q4 | $9.33K | Buy |
236
+155
| +191% | +$6.13K | ﹤0.01% | 1116 |
|
|
2022
Q3 | $3K | Sell |
81
-2
| -2% | -$74 | ﹤0.01% | 1829 |
|
|
2022
Q2 | $3K | Buy |
83
+32
| +63% | +$1.16K | ﹤0.01% | 1881 |
|
|
2022
Q1 | $2K | Hold |
51
| – | – | ﹤0.01% | 2019 |
|
|
2021
Q4 | $2K | Buy |
51
+5
| +11% | +$196 | ﹤0.01% | 2115 |
|
|
2021
Q3 | $2K | Sell |
46
-7
| -13% | -$304 | ﹤0.01% | 2156 |
|
|
2021
Q2 | $2K | Buy |
53
+5
| +10% | +$189 | ﹤0.01% | 2061 |
|
|
2021
Q1 | $2K | Buy |
48
+18
| +60% | +$750 | ﹤0.01% | 1855 |
|
|
2020
Q4 | $2K | Buy |
30
+19
| +173% | +$1.27K | ﹤0.01% | 1238 |
|
|
2020
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 1624 |
|